United Kingdom· GB-APID-33408311000001104
Zepatier 50mg/100mg tablets
A elbasvir and grazoprevir product containing elbasvir + grazoprevir, registered in United Kingdom by Merck Sharp & Dohme (UK) Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Elbasvir and grazoprevir is registered in 11 of 19 countries.
Countries holding a registration under ATC J05AP54 (elbasvir and grazoprevir), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Elbasvir and grazoprevir · ATC J05AP54
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Elbasvir + Grazoprevir
- Manufacturer
- Merck Sharp & Dohme (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AP54
- ATC class
- Elbasvir and grazoprevir
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5013945301809
- gtin5013945302400
- gtin00191778019520
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Elbasvir and grazoprevir in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZEPATIERMerck Sharp & Dohme B.V., Haarlem
- SpainZEPATIER 50MG/100MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Sharp & Dohme B.V.
- FinlandZEPATIERMerck Sharp & Dohme B.V.
- FranceZEPATIER 50 mg/100 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
- IrelandZEPATIER 50 mg/100 mg film-coated tabletsMerck Sharp & Dohme BV,
- IcelandZepatierMerck Sharp & Dohme B.V.*
- NetherlandsZepatier 50mg/100mg, filmomhulde tabletMerck Sharp & Dohme B.V.
- PolandZepatierMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zepatier
- Liechtenstein · Zepatier
- Norway · Zepatier
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1894dc77-9fac-4eaf-8205-25c11f3c2f88 GET /v1/drugs/1894dc77-9fac-4eaf-8205-25c11f3c2f88?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "33408311000001104",
"desc": "Zepatier 50mg/100mg tablets (Merck Sharp & Dohme (UK) Ltd)",
"form": "Oral tablet",
"vpid": "33422311000001107",
"source": "dmd",
"vtm_id": "781225004",
"strength": "50 mg",
"substance": "Elbasvir + Grazoprevir",
"ingredient": "Elbasvir",
"supplier_code": "39306911000001106"
}See everything about elbasvir and grazoprevir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.